Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/cd/7b/ef/cd7bef13-2f6c-ec7c-5332-0d014ca9308b/mza_2534052509331663784.jpg/600x600bb.jpg
MedtronicTalks
Tom Salemi
47 episodes
2 months ago
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
RSS
All content for MedtronicTalks is the property of Tom Salemi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
https://i1.sndcdn.com/artworks-p5Pz54iAOmVNCT6f-HhyBTw-t3000x3000.jpg
CFO Karen Parkhill discusses reorganization, results and success in building broader representation
MedtronicTalks
30 minutes 55 seconds
2 years ago
CFO Karen Parkhill discusses reorganization, results and success in building broader representation
Karen Parkhill assumed the role of chief financial officer at Medtronic six years ago, making her first move into the medical device industry. Over that time, Parkhill has helped oversee many transformations at Medtronic including the reorganization into 20 business units. As CFO, Parkhill also has had a hand in establishing gender equity pay at Medtronic and serves as the Executive Sponsor of the Medtronic PRIDE Employee Resource Group. She’s also active in cultivating and developing a rising number of women executives. In this interview we’ll talk with Karen Parkhill about the progress Medtronic has made in all those efforts and what she expects from the future. Thank you for listening to the MedtronicTalks Podcast. Subscribe to this podcast channel on any major podcast player.
MedtronicTalks
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.